FDA Approves KYGEVVI® (doxecitine and doxribtimine), the First and Only Treatment for Adults and Children Living with Thymidine Kinase 2 deficiency (TK2d), a Rare and Devastating Mitochondrial Disease ...
Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in adeno-associated virus (AAV) gene therapy, today announced a major expansion of its artificial intelligence and machine learning ...
Amazon launched a $68 million AI PhD Fellowship supporting over 100 students at nine elite universities including Johns ...
November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Hosted on MSN
5 Female Leaders Making a Global Impact in Business
Her experience also extends to major corporate environments, having served as Business Advisory Lead for Canada and Latin ...
Jason Snipe, the Founder and Chief Investment Officer of Odyssey Capital Advisors, recommended investors to “stay long” AbbVie Inc (NYSE:ABBV) during a recent program on CNBC.
The Memorandum of Agreement connects AUS coursework with professional practice. Mapei will host AUS students each year in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback